Naxicap Partners has acquired Groupe Moria
Naxicap Partners has acquired Groupe Moria from Bridgepoint Development Capital.
Naxicap Partners is a French private equity firm operating in all sectors and focusing on leverage buy-outs and growth capital. For more than 30 years, the firm has invested in ambitious companies in France, Benelux and Spain through controlling majority stakes. As of 31/12/2017, Naxicap Partners manages US$3.5 billion for BPCE Group (33%) and for global institutional investors (67%).
Groupe Moria manufactures and distributes ophthalmic surgery consumables, single use and reusable instruments addressing refractive, corneal, cataract and retinal procedures. The company benefits from strong know-how, combining handcraft capabilities and state-of-the-art technology located in two industrial facilities in France. Present in nearly 80 countries, the group reaches its end customers worldwide through to a tier-2 distribution model (direct sales to surgeons and healthcare facilities and indirect sales via distributors and wholesalers).
Bridgepoint Development Capital is a major international private equity group focused on buy-outs and growth capital investments, typically in businesses with an enterprise value of between US$22–267 million. The firm currently operates in the UK, France and the Nordic region.
Oaklins' team in France advised the buyer in this transaction.
Talk to the deal team
Narva clinics has been acquired by Narva Åderbråckscenter AB
The founder and some key employees of Åderbråcksspecialisterna Narva Kirurg Center AB and Narva Derma Center AB (Narva) have completed an MBO.Learn more
NS PARTNERS CO., LTD. has been acquired by JMDC Inc.
Noritsu Koki Co., Ltd has sold NS PARTNERS CO., LTD. to JMDC Inc.Learn more
Protalix BioTherapeutics, Inc. has completed a private stock placement
Protalix BioTherapeutics, Inc. has raised funds to refinance the company for further development.Learn more